Boston Taiwanese Biotechnology Association
Boston Taiwanese Biotechnology Association (BTBA) is a non-profit organization started in 2012 by a group of Taiwanese graduate students, postdocs and young professionals in the greater Boston area. Our goals are to foster individual career development, to enhance scientific collaborations, to facilitate interactions and to strengthen networking among academic and industrial bioscience communities in Taiwan and US.
Event
Career Development Series
Moderator Workshop
Career Development Series
Startups at National Biotechnology Research Park
Meet People, Catch Up With Friends, And Learn
Career Development Series
Drug Delivery—the current development and future
Register here
Podcast
S5 EP.2：美國藥物定價和保險給付體系 ft. Mike Lee 李和昭 MS, MBA 🎧
Oct 15, 2024
美國的高藥價和高醫療支出世界知名，光是處方藥的支出，就佔了全球處方藥物市場的四成，其中十款藥物在 2022 年佔了 Medicare 將近20%的支出（500 億美元），因此最近被《降低通膨法案 ...More info
S5 EP.1：新創公司大冒險 ft. 《三腳貓實驗室》姚若晴博士 🎧
Oct 01, 2024
《生技來一刻》第五季開張了！本集節目邀請到姚若晴博士，若晴博士班畢業之後，隨即加入南加州大洛杉磯區域的新創公司，後續因為公司的組織調整，他面臨在生技寒冬換工作的艱難挑戰，若晴很大方地和我們分享這 ...More info
S4 EP.19：魔術子彈──抗體藥物複合體 Antibody Drug Conjugate (ADC) ft. 張瑄玶博士 🎧
Aug 15, 2024
抗體藥物複合體 Antibody Drug Conjugate (ADC)，是蛋白質抗體和小分子藥物的結合，此技術利用抗體的專一性，將藥物帶至特定區域來殺癌細胞，減少對正常細胞的傷害。ADC 在 ...More info
Blog
藥廠投資組合管理．羅盈智醫師 (Dr. Ying-Chih (Paul) Lo)．訪談摘要
By 文：林書弘．圖：陳政儀．編輯：劉駿 on Apr, 2024
在現今的生技產業中，投資組合管理與數據分析技術的重要性日益增加。尤其在藥物開發這一高風險領域，有效的策略和先進的技術可以顯著提升研發的成功率及市場競爭力。透過近期與羅盈智醫師（Paul）的對話，我們得以深入了解這些策略如何在實際應用中發揮作用。 Paul目前在美國波士頓的 Novartis 藥廠擔任 Portfolio Data Science 部門的副總監，同時也是波士頓台灣醫師協會的會長。他的職業生涯跨越了醫療、人工智慧和商業策略，這使他對於藥廠如何進行投資組合管理有著獨到的見解。 ...Read more
Po-Jen (Will) Yen, Business Development
By Yi-Shan Chen on Mar, 2019
As a scientist in Biotech/Pharma, Business Development to me is a function that usually doesn’t have a lot of interaction with researchers unless they need data from you but the decisions they make influence researchers the most. ...Read more
TeYu Chen, Medicinal Chemist
By Yi-ying Chou on Nov, 2018
I always thought that doing biological experiments, like sitting long hours in front of tissue culture hood, can be physically challenging. When I chat with Ryan, I realized that medicinal chemists also have heavy workload on the bench side. In pharmaceutical company, chemists are not allowed to be ...Read more
2023 Symposium Sponsors
